Zura Bio Ltd

Zura Bio Ltd (NASDAQ: ZURA) is a clinical-stage biopharmaceutical company that completed its business combination with JAWS Healthcare Innovators Acquisition Corp, a blank-check vehicle sponsored by JAWS Capital LLC and backed by Peter Thiel, which held its IPO in 2021. The combined company focuses on autoimmune and inflammatory disease therapeutics and began trading under the ZURA ticker following the merger's close in 2023. Zura Bio filed an 8-K with the Securities and Exchange Commission on May 7, 2026, under accession number 0001628280-26-031701, reflecting a current reporting obligation. Sign up at SpacDesk for full filing history, sponsor profiles, and real-time data on ZURA and hundreds of other SPAC-origin companies.